The Patent Finder

Terms ending in 2031

Eagle Pharmaceuticals, Inc.

Every in-force patent on Eagle Pharmaceuticals, Inc.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,609,707Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In forceHigh confidence
US 9,000,021Method of Treating Bendamustine-Responsive Conditions in Patients Requiring Reduced Volumes for Administration
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In forceHigh confidence
US 9,034,908Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In forceHigh confidence
US 9,144,568Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In forceHigh confidence
US 9,265,831Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In forceHigh confidence
US 9,572,796Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In forceHigh confidence
US 9,572,797Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In forceHigh confidence
US 9,572,887Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In forceHigh confidence
US 9,572,888Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In forceHigh confidence
US 9,579,384Method of Treating Bendamustine-Responsive Conditions in Patients Requiring Reduced Volumes for Administration
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In forceHigh confidence
13 more term ends in 2031 · Pro
10 of 23 patents shown. Soonest term end first, then patent number.
Pro members see all 23.
Upgrade to Pro
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited